AMENDMENT No. 1 to LICENSE AGREEMENTLicense Agreement • September 18th, 2015 • Mirna Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 18th, 2015 Company IndustryThis AMENDMENT NO. 1 to LICENSE AGREEMENT (this “Amendment”) is made and entered into effective as of December 27, 2013 (the “Amendment Effective Date”), by and between Mirna Therapeutics, Inc., a Delaware corporation with offices at 2150 Woodward Street, Suite 100, Austin, Texas 78744 (“MirnaRx”), and Marina Biotech, Inc., a Delaware corporation with offices at 3830 Monte Villa Parkway, Bothell, Washington 98021 (“Marina Bio”).
AMENDMENT No. 1 to LICENSE AGREEMENTLicense Agreement • September 11th, 2015 • Mirna Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 11th, 2015 Company IndustryThis AMENDMENT NO. 1 to LICENSE AGREEMENT (this “Amendment”) is made and entered into effective as of December 27, 2013 (the “Amendment Effective Date”), by and between Mirna Therapeutics, Inc., a Delaware corporation with offices at 2150 Woodward Street, Suite 100, Austin, Texas 78744 (“MirnaRx”), and Marina Biotech, Inc., a Delaware corporation with offices at 3830 Monte Villa Parkway, Bothell, Washington 98021 (“Marina Bio”).
AMENDMENT No. 1 to LICENSE AGREEMENTLicense Agreement • August 24th, 2015 • Mirna Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 24th, 2015 Company IndustryThis AMENDMENT NO. 1 to LICENSE AGREEMENT (this “Amendment”) is made and entered into effective as of December 27, 2013 (the “Amendment Effective Date”), by and between Mirna Therapeutics, Inc., a Delaware corporation with offices at 2150 Woodward Street, Suite 100, Austin, Texas 78744 (“MirnaRx”), and Marina Biotech, Inc., a Delaware corporation with offices at 3830 Monte Villa Parkway, Bothell, Washington 98021 (“Marina Bio”).
AMENDMENT No. 1 to LICENSE AGREEMENTLicense Agreement • April 4th, 2014 • Mirna Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledApril 4th, 2014 Company IndustryThis AMENDMENT NO. 1 to LICENSE AGREEMENT (this “Amendment”) is made and entered into effective as of December 27, 2013 (the “Amendment Effective Date”), by and between Mirna Therapeutics, Inc., a Delaware corporation with offices at 2150 Woodward Street, Suite 100, Austin, Texas 78744 (“MirnaRx”), and Marina Biotech, Inc., a Delaware corporation with offices at 3830 Monte Villa Parkway, Bothell, Washington 98021 (“Marina Bio”).